XML 25 R5.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated statements of stockholders' equity (deficit) - USD ($)
$ in Thousands
Total
Common stock outstanding
Additional paid in capital
Treasury stock
Accumulated deficit
Balance at beginning of period (in shares) (Predecessor) at Dec. 31, 2015 1,404,309 1,404,309      
Balance at beginning of period (Predecessor) at Dec. 31, 2015 $ (620,357) $ 14 $ 431,307   $ (1,051,678)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Restricted stock forfeited (in shares) | Predecessor   (9,006)      
Restricted stock repurchased (in shares) | Predecessor (2,597) (2,597)      
Stock-based compensation | Predecessor $ (6,076)   (6,076)    
Restricted stock canceled (in shares) | Predecessor (9,006)        
Net income (loss) | Predecessor $ (415,720)       (415,720)
Balance at end of period (in shares) (Predecessor) at Dec. 31, 2016 1,392,706 1,392,706      
Balance at end of period (Predecessor) at Dec. 31, 2016 $ (1,042,153) $ 14 425,231   (1,467,398)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Restricted stock forfeited (in shares) | Predecessor (1,454) (1,454)      
Stock-based compensation | Predecessor $ 194   194    
Restricted stock canceled (in shares) | Predecessor (8,964) (8,964)      
Net income (loss) | Predecessor $ 1,041,959       1,041,959
Balance at end of period (in shares) (Predecessor) at Mar. 21, 2017 1,382,288 1,382,288      
Balance at end of period (in shares) at Mar. 21, 2017 44,982,142 44,982,142      
Balance at end of period (Predecessor) at Mar. 21, 2017 $ (1,012,089) $ 14 425,425   (425,439)
Balance at end of period at Mar. 21, 2017 $ 949,063 $ 450 948,613    
Balance at beginning of period (in shares) (Predecessor) at Dec. 31, 2016 1,392,706 1,392,706      
Balance at beginning of period (Predecessor) at Dec. 31, 2016 $ (1,042,153) $ 14 425,231   (1,467,398)
Balance at end of period (in shares) at Dec. 31, 2017 46,827,762 46,827,762      
Balance at end of period at Dec. 31, 2017 $ 842,766 $ 468 961,200 $ 0 (118,902)
Balance at beginning of period (in shares) (Predecessor) at Mar. 21, 2017 1,382,288 1,382,288      
Balance at beginning of period (in shares) at Mar. 21, 2017 44,982,142 44,982,142      
Balance at beginning of period (Predecessor) at Mar. 21, 2017 $ (1,012,089) $ 14 425,425   (425,439)
Balance at beginning of period at Mar. 21, 2017 $ 949,063 $ 450 948,613    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation (in shares) 1,853,236 1,853,236      
Stock-based compensation $ 12,605 $ 18 12,587    
Restricted stock canceled (in shares) (7,616) (7,616)      
Net income (loss) $ (118,902)       (118,902)
Balance at end of period (in shares) at Dec. 31, 2017 46,827,762 46,827,762      
Balance at end of period at Dec. 31, 2017 $ 842,766 $ 468 961,200 0 (118,902)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Restricted stock forfeited (in shares) (231,746) (231,746)      
Restricted stock forfeited $ (2) $ (2)      
Repurchase of common stock (in shares) (261,103) (261,103)      
Repurchase of common stock $ (4,936)     (4,936)  
Stock-based compensation (in shares)   55,600      
Stock-based compensation 13,417 $ 1 13,416    
Net income (loss) $ 33,442       33,442
Balance at end of period (in shares) at Dec. 31, 2018 46,390,513 46,390,513      
Balance at end of period at Dec. 31, 2018 $ 884,687 $ 467 $ 974,616 $ (4,936) $ (85,460)